Selection Against Mutant Alleles in Blood Leukocytes is a Consistent Feature in Incontinentia Pigmenti Type 2
Incontinentia Pigmenti 2 (IP2) is an X-linked dominant disorder with male lethality. Affected females display a characteristic skin eruption that evolves through four classic stages, frequently accompanied by dental and retinal abnormalities. Non-random (skewed) X-inactivation in peripheral blood le...
Gespeichert in:
Veröffentlicht in: | Human molecular genetics 1996-11, Vol.5 (11), p.1777-1783 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1783 |
---|---|
container_issue | 11 |
container_start_page | 1777 |
container_title | Human molecular genetics |
container_volume | 5 |
creator | Parrish, Julia E. Scheuerle, Angela E. Lewis, Richard A. Levy, Moise L. Nelson, David L. |
description | Incontinentia Pigmenti 2 (IP2) is an X-linked dominant disorder with male lethality. Affected females display a characteristic skin eruption that evolves through four classic stages, frequently accompanied by dental and retinal abnormalities. Non-random (skewed) X-inactivation in peripheral blood leukocytes and in fibroblasts has been observed in females with IP2; however, sample sizes have been small and methods of analysis varied. We have examined X-inactivation in a large group of multigenerational IP2 families, in smaller families, and in isolated cases. Ninety-eight percent of affected females in multigenerational IP2 pedigrees show completely skewed patterns of X-inactivation, while only ∼10% of a normal control population is skewed. Results both in small families and in new mutation cases with subsequent segregation consistent with Xq28 linkage are similar. Isolated cases show a lower percentage (85%) of skewed affected individuals; this difference may be due to inaccurate clinical ascertainment. The parent of origin of new mutations could be determined in 15 families; paternal new mutations were twice as common as maternal. Fibro-blast subclones from a biopsy at the boundary of a skin lesion in a newborn IP2 patient were isolated, and clones with either one or the other X active were identified, demonstrating that cells with the active disease-bearing X chromosome are still present in stage I skin lesions. |
doi_str_mv | 10.1093/hmg/5.11.1777 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78543026</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78543026</sourcerecordid><originalsourceid>FETCH-LOGICAL-c460t-982cf819ffda5b7704a1bac76232d41c4a766844ee2b6cd9f7dad549ee200c063</originalsourceid><addsrcrecordid>eNpNkE2P0zAQhi0EWroLR45IPiBu6frb8bFb2A9RBIhFIC7W1HGK2cQusSPRf0-irSpOHs_7aGb0IPSKkiUlhl_-6neXcknpkmqtn6AFFYpUjNT8KVoQo0SlDFHP0XnOvwmhSnB9hs5qwzghaoH6r77zroQU8WoHIeaCP44FYsGrrpuijEPEV11KDd748SG5Q5l7GQNep5hDLn5irz2UcfAzexddiiXEqR0Afw67fq7w_WHvMXuBnrXQZf_y-F6gb9fv79e31ebTzd16tancdHypTM1cW1PTtg3IrdZEAN2C04px1gjqBGilaiG8Z1vlGtPqBhopzPQnxBHFL9Dbx7n7If0ZfS62D9n5roPo05itrqXghM1g9Qi6IeU8-Nbuh9DDcLCU2FmvnfRaaSm1s96Jf30cPG5735zoo88pf3PMITvo2gGiC_mEcSalNP-tnf39PcUwPFiluZb29sdPe_Vd6w9f3jHL-D8s8ZKG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78543026</pqid></control><display><type>article</type><title>Selection Against Mutant Alleles in Blood Leukocytes is a Consistent Feature in Incontinentia Pigmenti Type 2</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Oxford Journals</source><creator>Parrish, Julia E. ; Scheuerle, Angela E. ; Lewis, Richard A. ; Levy, Moise L. ; Nelson, David L.</creator><creatorcontrib>Parrish, Julia E. ; Scheuerle, Angela E. ; Lewis, Richard A. ; Levy, Moise L. ; Nelson, David L.</creatorcontrib><description>Incontinentia Pigmenti 2 (IP2) is an X-linked dominant disorder with male lethality. Affected females display a characteristic skin eruption that evolves through four classic stages, frequently accompanied by dental and retinal abnormalities. Non-random (skewed) X-inactivation in peripheral blood leukocytes and in fibroblasts has been observed in females with IP2; however, sample sizes have been small and methods of analysis varied. We have examined X-inactivation in a large group of multigenerational IP2 families, in smaller families, and in isolated cases. Ninety-eight percent of affected females in multigenerational IP2 pedigrees show completely skewed patterns of X-inactivation, while only ∼10% of a normal control population is skewed. Results both in small families and in new mutation cases with subsequent segregation consistent with Xq28 linkage are similar. Isolated cases show a lower percentage (85%) of skewed affected individuals; this difference may be due to inaccurate clinical ascertainment. The parent of origin of new mutations could be determined in 15 families; paternal new mutations were twice as common as maternal. Fibro-blast subclones from a biopsy at the boundary of a skin lesion in a newborn IP2 patient were isolated, and clones with either one or the other X active were identified, demonstrating that cells with the active disease-bearing X chromosome are still present in stage I skin lesions.</description><identifier>ISSN: 0964-6906</identifier><identifier>ISSN: 1460-2083</identifier><identifier>EISSN: 1460-2083</identifier><identifier>DOI: 10.1093/hmg/5.11.1777</identifier><identifier>PMID: 8923006</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adult ; Alleles ; Biological and medical sciences ; Cell Line ; Dermatology ; Dosage Compensation, Genetic ; Female ; Fibroblasts ; Genetic Linkage ; Glucosephosphate Dehydrogenase - genetics ; Humans ; Incontinentia Pigmenti - genetics ; Infant, Newborn ; Lymphocytes ; Male ; Medical sciences ; Mutation ; Pedigree ; Pigmentary diseases of the skin ; Skin - cytology ; X Chromosome - genetics</subject><ispartof>Human molecular genetics, 1996-11, Vol.5 (11), p.1777-1783</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c460t-982cf819ffda5b7704a1bac76232d41c4a766844ee2b6cd9f7dad549ee200c063</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3255596$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8923006$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Parrish, Julia E.</creatorcontrib><creatorcontrib>Scheuerle, Angela E.</creatorcontrib><creatorcontrib>Lewis, Richard A.</creatorcontrib><creatorcontrib>Levy, Moise L.</creatorcontrib><creatorcontrib>Nelson, David L.</creatorcontrib><title>Selection Against Mutant Alleles in Blood Leukocytes is a Consistent Feature in Incontinentia Pigmenti Type 2</title><title>Human molecular genetics</title><addtitle>Human Molecular Genetics</addtitle><description>Incontinentia Pigmenti 2 (IP2) is an X-linked dominant disorder with male lethality. Affected females display a characteristic skin eruption that evolves through four classic stages, frequently accompanied by dental and retinal abnormalities. Non-random (skewed) X-inactivation in peripheral blood leukocytes and in fibroblasts has been observed in females with IP2; however, sample sizes have been small and methods of analysis varied. We have examined X-inactivation in a large group of multigenerational IP2 families, in smaller families, and in isolated cases. Ninety-eight percent of affected females in multigenerational IP2 pedigrees show completely skewed patterns of X-inactivation, while only ∼10% of a normal control population is skewed. Results both in small families and in new mutation cases with subsequent segregation consistent with Xq28 linkage are similar. Isolated cases show a lower percentage (85%) of skewed affected individuals; this difference may be due to inaccurate clinical ascertainment. The parent of origin of new mutations could be determined in 15 families; paternal new mutations were twice as common as maternal. Fibro-blast subclones from a biopsy at the boundary of a skin lesion in a newborn IP2 patient were isolated, and clones with either one or the other X active were identified, demonstrating that cells with the active disease-bearing X chromosome are still present in stage I skin lesions.</description><subject>Adult</subject><subject>Alleles</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Dermatology</subject><subject>Dosage Compensation, Genetic</subject><subject>Female</subject><subject>Fibroblasts</subject><subject>Genetic Linkage</subject><subject>Glucosephosphate Dehydrogenase - genetics</subject><subject>Humans</subject><subject>Incontinentia Pigmenti - genetics</subject><subject>Infant, Newborn</subject><subject>Lymphocytes</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mutation</subject><subject>Pedigree</subject><subject>Pigmentary diseases of the skin</subject><subject>Skin - cytology</subject><subject>X Chromosome - genetics</subject><issn>0964-6906</issn><issn>1460-2083</issn><issn>1460-2083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkE2P0zAQhi0EWroLR45IPiBu6frb8bFb2A9RBIhFIC7W1HGK2cQusSPRf0-irSpOHs_7aGb0IPSKkiUlhl_-6neXcknpkmqtn6AFFYpUjNT8KVoQo0SlDFHP0XnOvwmhSnB9hs5qwzghaoH6r77zroQU8WoHIeaCP44FYsGrrpuijEPEV11KDd748SG5Q5l7GQNep5hDLn5irz2UcfAzexddiiXEqR0Afw67fq7w_WHvMXuBnrXQZf_y-F6gb9fv79e31ebTzd16tancdHypTM1cW1PTtg3IrdZEAN2C04px1gjqBGilaiG8Z1vlGtPqBhopzPQnxBHFL9Dbx7n7If0ZfS62D9n5roPo05itrqXghM1g9Qi6IeU8-Nbuh9DDcLCU2FmvnfRaaSm1s96Jf30cPG5735zoo88pf3PMITvo2gGiC_mEcSalNP-tnf39PcUwPFiluZb29sdPe_Vd6w9f3jHL-D8s8ZKG</recordid><startdate>19961101</startdate><enddate>19961101</enddate><creator>Parrish, Julia E.</creator><creator>Scheuerle, Angela E.</creator><creator>Lewis, Richard A.</creator><creator>Levy, Moise L.</creator><creator>Nelson, David L.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19961101</creationdate><title>Selection Against Mutant Alleles in Blood Leukocytes is a Consistent Feature in Incontinentia Pigmenti Type 2</title><author>Parrish, Julia E. ; Scheuerle, Angela E. ; Lewis, Richard A. ; Levy, Moise L. ; Nelson, David L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c460t-982cf819ffda5b7704a1bac76232d41c4a766844ee2b6cd9f7dad549ee200c063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adult</topic><topic>Alleles</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Dermatology</topic><topic>Dosage Compensation, Genetic</topic><topic>Female</topic><topic>Fibroblasts</topic><topic>Genetic Linkage</topic><topic>Glucosephosphate Dehydrogenase - genetics</topic><topic>Humans</topic><topic>Incontinentia Pigmenti - genetics</topic><topic>Infant, Newborn</topic><topic>Lymphocytes</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mutation</topic><topic>Pedigree</topic><topic>Pigmentary diseases of the skin</topic><topic>Skin - cytology</topic><topic>X Chromosome - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Parrish, Julia E.</creatorcontrib><creatorcontrib>Scheuerle, Angela E.</creatorcontrib><creatorcontrib>Lewis, Richard A.</creatorcontrib><creatorcontrib>Levy, Moise L.</creatorcontrib><creatorcontrib>Nelson, David L.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human molecular genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Parrish, Julia E.</au><au>Scheuerle, Angela E.</au><au>Lewis, Richard A.</au><au>Levy, Moise L.</au><au>Nelson, David L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Selection Against Mutant Alleles in Blood Leukocytes is a Consistent Feature in Incontinentia Pigmenti Type 2</atitle><jtitle>Human molecular genetics</jtitle><addtitle>Human Molecular Genetics</addtitle><date>1996-11-01</date><risdate>1996</risdate><volume>5</volume><issue>11</issue><spage>1777</spage><epage>1783</epage><pages>1777-1783</pages><issn>0964-6906</issn><issn>1460-2083</issn><eissn>1460-2083</eissn><abstract>Incontinentia Pigmenti 2 (IP2) is an X-linked dominant disorder with male lethality. Affected females display a characteristic skin eruption that evolves through four classic stages, frequently accompanied by dental and retinal abnormalities. Non-random (skewed) X-inactivation in peripheral blood leukocytes and in fibroblasts has been observed in females with IP2; however, sample sizes have been small and methods of analysis varied. We have examined X-inactivation in a large group of multigenerational IP2 families, in smaller families, and in isolated cases. Ninety-eight percent of affected females in multigenerational IP2 pedigrees show completely skewed patterns of X-inactivation, while only ∼10% of a normal control population is skewed. Results both in small families and in new mutation cases with subsequent segregation consistent with Xq28 linkage are similar. Isolated cases show a lower percentage (85%) of skewed affected individuals; this difference may be due to inaccurate clinical ascertainment. The parent of origin of new mutations could be determined in 15 families; paternal new mutations were twice as common as maternal. Fibro-blast subclones from a biopsy at the boundary of a skin lesion in a newborn IP2 patient were isolated, and clones with either one or the other X active were identified, demonstrating that cells with the active disease-bearing X chromosome are still present in stage I skin lesions.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>8923006</pmid><doi>10.1093/hmg/5.11.1777</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0964-6906 |
ispartof | Human molecular genetics, 1996-11, Vol.5 (11), p.1777-1783 |
issn | 0964-6906 1460-2083 1460-2083 |
language | eng |
recordid | cdi_proquest_miscellaneous_78543026 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Oxford Journals |
subjects | Adult Alleles Biological and medical sciences Cell Line Dermatology Dosage Compensation, Genetic Female Fibroblasts Genetic Linkage Glucosephosphate Dehydrogenase - genetics Humans Incontinentia Pigmenti - genetics Infant, Newborn Lymphocytes Male Medical sciences Mutation Pedigree Pigmentary diseases of the skin Skin - cytology X Chromosome - genetics |
title | Selection Against Mutant Alleles in Blood Leukocytes is a Consistent Feature in Incontinentia Pigmenti Type 2 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T07%3A50%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Selection%20Against%20Mutant%20Alleles%20in%20Blood%20Leukocytes%20is%20a%20Consistent%20Feature%20in%20Incontinentia%20Pigmenti%20Type%202&rft.jtitle=Human%20molecular%20genetics&rft.au=Parrish,%20Julia%20E.&rft.date=1996-11-01&rft.volume=5&rft.issue=11&rft.spage=1777&rft.epage=1783&rft.pages=1777-1783&rft.issn=0964-6906&rft.eissn=1460-2083&rft_id=info:doi/10.1093/hmg/5.11.1777&rft_dat=%3Cproquest_cross%3E78543026%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78543026&rft_id=info:pmid/8923006&rfr_iscdi=true |